Sebastian E. Sattui

Has grant

Assistant Professor

University of Pittsburgh

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sebastian E. Sattui is an Assistant Professor at the University of Pittsburgh, USA. His research primarily focuses on frailty and its implications in rheumatic diseases, particularly in aging populations. Recent studies highlight his work on the outcomes of patients with vasculitis, diversity in clinical trials for myositis, and the management of polymyalgia rheumatica. His contributions aim to enhance the understanding and care of rheumatologic conditions in older adults.

Recent Grants

Grant: Close

Vasculitis Foundation/Vasculitis Clinical Research Consortium Fellowship Award

Open Date: 2019-07-01

Close Date: 2021-06-01

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

View details

Kresten Krarup Keller

DENMARK

View details

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian E. Sattui

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (24)

Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials

Efficacy and safety of avacopan in patients aged 65 years and older with ANCA-associated vasculitis: a post hoc analysis of data from the ADVOCATE trial.

Frailty and Associated Outcomes in Patients With Vasculitis

Understanding Fatigue and Sleep Disturbance in Polymyalgia Rheumatica: Redefining the Patient Experience and Opportunities for Intervention

Prevalence of Frailty and Associated Factors in a US‐Wide Cohort of Rheumatic Diseases

Advancing Rheumatologic Care in Older Adults: Highlights From the 2024 American Geriatrics Society Annual Scientific Meeting

Frailty in older adults with systemic lupus erythematosus and emergency department utilization: an administrative claims data analysis of Medicare beneficiaries

Annals On Call - Diagnosing Giant Cell Arteritis

The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study

Current perspective on infections and mitigation strategies in primary systemic vasculitis

Patient‐Reported Outcomes in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Are the Answers in Front of Our Noses?

Frailty and rheumatic diseases: evidence to date and lessons learned

Frailty and emergency department utilisation in adults with systemic lupus erythematosus ≤65 years of age: an administrative claims data analysis of Medicaid beneficiaries

Incidence of Pneumocystis jiroveci pneumonia in patients with ANCA‐associated vasculitis initiating therapy with rituximab or cyclophosphamide

Treatment of Polymyalgia Rheumatica by Rheumatology Providers: Analysis from the ACR Rheumatology Informatics System for Effectiveness registry

Where did that trial go? Unpublished clinical trials in rheumatology and potential implications

Supporting International Medical Graduates in Rheumatology: A Call to Action

Keep It in Mind: Assessing the Risk of Dementia in Patients With Rheumatoid Arthritis and Opportunities for Intervention

Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group

Association of patient copayment and medication adherence in systemic lupus erythematosus

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset

Prevalence of frailty in patients with polymyalgia rheumatica and association with health-related quality of life, cognition and sarcopenia

Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Where do we go after GiACTA?

Collaborators (10)

Rachael Stovall

Iris Navarro-Millán

Bharat Kumar

DUVURU GEETHA

Anisha B. Dua

Kresten Krarup Keller

Jan Halbritter

Helen Isobel Keen

Raisa Silva

Latika Gupta

Make your next move.